Kcentra 500UNIT 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FHYX5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,896
Award facts
- Contract value 100% obligated
- $11,895.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $11,895.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 500 units of KCENTRA on January 6, 2026. This delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense pharmaceutical supply chain, leveraging its established relationships and broad product portfolio to support military healthcare operations.
This delivery order is issued under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy through which DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (SPE2DR) valued at $500 million with a completion date of December 31, 2036. The broader PPV-G GEN V program authorizes the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system, with ultimate completion of this specific delivery order scheduled for January 13, 2026.
Quick answers
Who was awarded contract SPE2DR26FHYX5?
SPE2DR26FHYX5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FHYX5 worth?
The government has obligated $11,896 on SPE2DR26FHYX5.
Is contract SPE2DR26FHYX5 an order under another contract?
Yes. SPE2DR26FHYX5 is a delivery order under SPE2DR25D9762, an indefinite delivery contract.
Was contract SPE2DR26FHYX5 competed?
The extent of competition for SPE2DR26FHYX5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award